Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Innoviva Inc., 3 years.
Innoviva Inc.
Director
Armata Pharmaceuticals Inc.
Director · Chief Executive Officer
Chief executive roles
Armata Pharmaceuticals Inc.
· Chief Executive Officer
Since July 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Armata Pharmaceuticals Inc. | Shares withheld for tax | −14,041 | $4.26 | $59,815 |
| Mar 14, 2026 | Armata Pharmaceuticals Inc. | Shares withheld for tax | −4,919 | $10.54 | $51,846 |
| Jul 10, 2025 | Armata Pharmaceuticals Inc. | Shares withheld for tax | −13,637 | $2.27 | $30,956 |
| Mar 14, 2025 | Armata Pharmaceuticals Inc. | Shares withheld for tax | −6,061 | $1.95 | $11,819 |
| Jul 10, 2024 | Armata Pharmaceuticals Inc. | Shares withheld for tax | −22,925 | $2.68 | $61,439 |
| Mar 14, 2024 | Armata Pharmaceuticals Inc. | Grant or award | +60,000 | — | — |
| Dec 21, 2023 | Armata Pharmaceuticals Inc. | Grant or award | +200,000 | — | — |
| May 22, 2023 | Innoviva Inc. | Grant or award | +16,495 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.